Armata Pharmaceuticals (ARMP) Enterprise Value (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Enterprise Value of -$4.8 million for Q1 2026, up 58.93% on a YoY basis from -$3.0 million in Q1 2025, and up 44.75% sequentially from -$8.7 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Enterprise Value (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Enterprise Value data on file, last reported at -$4.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 58.93% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2026 stood at -$4.8 million (up 58.93% YoY), and the FY2025 full-year result was -$8.7 million, up 6.49% from the prior year.
- Enterprise Value grew to -$4.8 million in Q1 2026, from -$8.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.3 million in Q2 2025 to a low of -$46.4 million in Q1 2022.
- A 5-year average of -$19.6 million and a median of -$14.9 million in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value slumped 111.99% in 2024 and surged 83.61% in 2025, its largest moves.
- Tracing ARMP's Enterprise Value over 5 years: stood at -$14.9 million in 2022, then climbed by 8.95% to -$13.5 million in 2023, then soared by 31.29% to -$9.3 million in 2024, then advanced by 6.49% to -$8.7 million in 2025, then surged by 44.75% to -$4.8 million in 2026.
- Business Quant data shows ARMP's Enterprise Value at -$4.8 million in Q1 2026, -$8.7 million in Q4 2025, and -$14.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | -4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.80 Mn |
| Dec 31, 2025 | -8.69 Mn |
| Sep 30, 2025 | -14.76 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Mar 31, 2025 | -11.69 Mn |
| Dec 31, 2024 | -9.29 Mn |
| Sep 30, 2024 | -17.14 Mn |
| Jun 30, 2024 | -26.41 Mn |
| Mar 31, 2024 | -37.86 Mn |
| Dec 31, 2023 | -13.52 Mn |
| Sep 30, 2023 | -23.96 Mn |
| Jun 30, 2023 | -12.46 Mn |
| Mar 31, 2023 | -25.11 Mn |
| Dec 31, 2022 | -14.85 Mn |
| Sep 30, 2022 | -25.38 Mn |
| Jun 30, 2022 | -36.98 Mn |
| Mar 31, 2022 | -46.41 Mn |
| Dec 31, 2021 | -10.29 Mn |
| Sep 30, 2021 | -12.08 Mn |
| Jun 30, 2021 | -17.54 Mn |